KRAS 枯竭抑制铁和影响白内障中的河马通路
Hongda Jiang1, Yinggui Yu2, Yu Yan2
1Department of Laboratory Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou City, Sichuan Province, China.
General physiology and biophysics
|May 22, 2024
概括
这项研究揭示了基斯鼠肉瘤 (KRAS) 在白内障发育中发挥作用,通过影响细胞死亡过程铁亡. 降低KRAS的调节可能为预防白内障导致的视力丧失提供了一个新的治疗策略.
科学领域:
- 眼科医生 眼科 眼科
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 白内障是全球失明的主要原因,其特点是透镜变暗.
- 了解白内障形成背后的分子机制对于开发有效治疗方法至关重要.
研究的目的:
- 为了研究基尔斯大鼠肉瘤 (KRAS) 在白内障病因发生过程中的作用.
- 阐明KRAS影响白内障发育的潜在机制,特别是关于铁死.
主要方法:
- 生物信息分析以确定与铁结相关的差异表达基因 (DEGs) 和白内障中的关键基因.
- 在SRA01/04细胞中诱导铁亡,使用过氧化 (H2O2) 和埃拉斯.
- 通过测量细胞内铁,谷氨 (GSH) 和马隆迪 (MDA) 水平来验证铁.
- 通过功能测试和西式斑点测试,评估KRAS缺乏对铁和Hippo信号通路的影响.
主要成果:
- 在白内障细胞模型中确定了73个与铁灭相关的DEG,其中6个核心基因被上调.
- 在SRA01/04细胞中,H2O2诱导的铁死显示活力下降,铁和MDA增加,GSH减少,COX2升高,GPX4.4减少.
- KRAS knockdown改善了这些铁亡标记物,并与Hippo信号通路激活有关.
结论:
- 在白内障的背景下,KRAS在调节铁亡中发挥着重要作用.
- 降低KRAS的调节可能会抑制铁亡并调节Hippo信号通路,这表明白内障的潜在治疗标.
更多相关视频
10:39Author Spotlight: Improved Lipofuscin Models and Quantification of Outer Segment Phagocytosis Capacity in Highly Polarized Human Retinal Pigment Epithelial Cultures
Published on: April 14, 2023
2.5K
05:19Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery
Published on: December 1, 2023
1.0K
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Hedgehog Signaling Pathway
7.3K
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.3K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
Necrosis
4.5K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.5K
